BARCLAYS PLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 157 filers reported holding MERSANA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$43
-93.0%
34,154
-81.7%
0.00%
Q2 2023$614
-24.7%
186,929
-5.6%
0.00%
Q1 2023$815
-40.1%
198,033
-14.7%
0.00%
-100.0%
Q4 2022$1,360
-99.9%
232,088
+71.0%
0.00%0.0%
Q3 2022$918,000
+484.7%
135,722
+298.2%
0.00%
Q2 2022$157,000
-5.4%
34,087
-18.0%
0.00%
Q1 2022$166,000
-85.2%
41,574
-76.9%
0.00%
Q4 2021$1,122,000
+259.6%
180,238
+445.9%
0.00%
Q3 2021$312,000
-59.9%
33,016
-42.4%
0.00%
Q2 2021$778,000
-61.7%
57,365
-54.3%
0.00%
-100.0%
Q1 2021$2,030,000
+269.8%
125,428
+508.2%
0.00%
Q4 2020$549,000
+2.0%
20,624
-28.7%
0.00%
Q3 2020$538,000
-18.4%
28,921
+2.7%
0.00%
-100.0%
Q2 2020$659,000
+336.4%
28,150
+8.5%
0.00%
Q1 2020$151,000
-39.1%
25,945
-40.0%
0.00%
Q4 2019$248,000
+439.1%
43,241
+48.0%
0.00%
Q3 2019$46,000
-60.0%
29,216
+3.3%
0.00%
Q2 2019$115,000
+62.0%
28,294
+108.8%
0.00%
Q1 2019$71,000
+294.4%
13,553
+205.5%
0.00%
Q4 2018$18,000
-80.4%
4,437
-51.6%
0.00%
Q3 2018$92,000
+100.0%
9,173
+250.6%
0.00%
Q2 2018$46,000
-32.4%
2,616
-38.6%
0.00%
Q1 2018$68,000
+423.1%
4,258
+431.6%
0.00%
Q4 2017$13,000
-80.3%
801
-78.9%
0.00%
Q3 2017$66,0003,8020.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders